| ABT |
Abbott Laboratories |
72%
|
Reciprocal relationship from ABT graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operati… |
| ABT |
Abbott Laboratories |
72%
|
r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh… |
| BDX |
Becton, Dickinson and Company |
72%
|
Reciprocal relationship from BDX graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operati… |
| BDX |
Becton, Dickinson and Company |
72%
|
r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh… |
| JNJ |
Johnson & Johnson |
72%
|
Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: Reciprocal relationship from JNJ graph: Reciprocal relationship from AORT graph: r in Iran; however, it is difficult t… |
| JNJ |
Johnson & Johnson |
72%
|
r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh… |
| BAX |
Baxter International Inc. |
62%
|
Reciprocal relationship from BAX graph: Reciprocal relationship from AORT graph: . Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes… |
| BAXTER-INTERNATIONAL-INC |
BAXTER-INTERNATIONAL-INC |
62%
|
. Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year en… |
| COMPANY-INTEGRA-LIFE-SCIENCES-LIFENET-HEALTH-COR |
COMPANY-INTEGRA-LIFE-SCIENCES-LIFENET-HEALTH-COR |
62%
|
r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh… |
| GRENA-LIMITED |
GRENA-LIMITED |
62%
|
r in Iran; however, it is difficult to predict the ultimate course of these conflicts and we may face business operations and supply chain disruptions as a result, including disruptions related to sh… |
| JOTEC-GMBH-ON-X-LIFE-TECHNOLOGIES-INC-HEMOSPHERE |
JOTEC-GMBH-ON-X-LIFE-TECHNOLOGIES-INC-HEMOSPHERE |
62%
|
about the timing and results of our clinical trials, approvals, and product commercialization and launches; • Our expectations related to anticipated expansion of our business and the sufficiency of … |
| STARCH-MEDICAL-INC |
STARCH-MEDICAL-INC |
62%
|
. Significant Accounting Policies A summary of our significant accounting policies is included in Note 1 of the “Notes to Consolidated Financial Statements” contained in our Form 10-K for the year en… |